Topic: --NEW-- BCG or early cystectomy? Challenges in high risk NMIBC
Earn accreditation points
Finish 5 cases, answer 10 questions and Earn 1 credit.
This topic consists of 5 cases
Disease Area: Bladder cancer
Background: High-risk NMIBC includes T1 tumours, G3 (high grade) tumours, carcinoma in situ (CIS) or multiple, recurrent and large (>3 cm) TaG1/G2/LG tumours, according to the EAU guidelines.
Educational Objective: Gain insight into indications for second resection and for Bacillus Calmette-Guérin (BCG) therapy; treatment options after BCG failure and recurrence after BCG therapy; indications for radical cystectomy in NMIBC.
Specialty: Urology, medical oncology
Target Audience: CME (basic, intermediate), Residents (senior)
Latest update: July 2019